1
|
Lizunova SA, Tsvetkov VB, Skvortsov DA, Kamzeeva PN, Ivanova OM, Vasilyeva LA, Chistov AA, Belyaev ES, Khrulev AA, Vedekhina TS, Bogomazova AN, Lagarkova MA, Varizhuk AM, Aralov AV. Anticancer activity of G4-targeting phenoxazine derivatives in vitro. Biochimie 2022; 201:43-54. [PMID: 35817132 DOI: 10.1016/j.biochi.2022.07.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2022] [Revised: 06/27/2022] [Accepted: 07/01/2022] [Indexed: 11/02/2022]
Abstract
G4-stabilizing ligands are now being considered as anticancer, antiviral and antibacterial agents. Phenoxazine is a promising scaffold for the development of G4 ligands. Here, we profiled two known phenoxazine-based nucleoside analogs and five new nucleoside and non-nucleoside derivatives against G4 targets from telomere repeats and the KIT promoter region. Leading new derivatives exhibited remarkably high G4-stabilizing effects (comparable or superior to the effects of the commonly used selective G4 ligands PDS and NMM) and selectivity toward G4s over duplex (superior to BRACO-19). All phenoxazine-based ligands inhibited cellular metabolic activity. The phenoxazine derivatives were particularly toxic for lung adenocarcinoma cells A549' and human liver cancer cells HepG2 (CC50 of the nucleoside analogues in the nanomolar range), but also affected breast cancer cells MCF7, as well as immortalized fibroblasts VA13 and embryonic kidney cells HEK293t (CC50 in the micromolar range). Importantly, the CC50 values varied mostly in accordance with G4-binding affinities and G4-stabilizing effects, and the phenoxazine derivatives localized in the cell nuclei, which corroborates G4-mediated mechanisms of action.
Collapse
Affiliation(s)
- Sofia A Lizunova
- Federal Research and Clinical Center of Physical-Chemical Medicine, Malaya Pirogovskaya Str. 1a, Moscow, 119435, Russia
| | - Vladimir B Tsvetkov
- Federal Research and Clinical Center of Physical-Chemical Medicine, Malaya Pirogovskaya Str. 1a, Moscow, 119435, Russia; I.M. Sechenov First Moscow State Medical University, Trubetskaya Str. 8-2, Moscow, 119991, Russia; A.V. Topchiev Institute of Petrochemical Synthesis RAS, Leninsky Prospect Str. 29, Moscow, 119991, Russia.
| | - Dmitry A Skvortsov
- Lomonosov Moscow State University, Department of Chemistry and Faculty of Bioengineering and Bioinformatics, Moscow, 119991, Russia
| | - Polina N Kamzeeva
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya Str. 16/10, Moscow, 117997, Russia
| | - Olga M Ivanova
- Federal Research and Clinical Center of Physical-Chemical Medicine, Malaya Pirogovskaya Str. 1a, Moscow, 119435, Russia; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Malaya Pirogovskaya Str. 1a, Moscow, 119435, Russia
| | - Lilja A Vasilyeva
- Lomonosov Moscow State University, Department of Chemistry and Faculty of Bioengineering and Bioinformatics, Moscow, 119991, Russia
| | - Alexey A Chistov
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya Str. 16/10, Moscow, 117997, Russia
| | - Evgeny S Belyaev
- Frumkin Institute of Physical Chemistry and Electrochemistry of the Russian Academy of Science, Moscow, 119071, Russia
| | - Alexei A Khrulev
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya Str. 16/10, Moscow, 117997, Russia
| | - Tatiana S Vedekhina
- Federal Research and Clinical Center of Physical-Chemical Medicine, Malaya Pirogovskaya Str. 1a, Moscow, 119435, Russia; G4_Interact, USERN, University of Pavia, 27100 Pavia, Italy
| | - Alexandra N Bogomazova
- Federal Research and Clinical Center of Physical-Chemical Medicine, Malaya Pirogovskaya Str. 1a, Moscow, 119435, Russia; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Malaya Pirogovskaya Str. 1a, Moscow, 119435, Russia
| | - Maria A Lagarkova
- Federal Research and Clinical Center of Physical-Chemical Medicine, Malaya Pirogovskaya Str. 1a, Moscow, 119435, Russia; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Malaya Pirogovskaya Str. 1a, Moscow, 119435, Russia
| | - Anna M Varizhuk
- Federal Research and Clinical Center of Physical-Chemical Medicine, Malaya Pirogovskaya Str. 1a, Moscow, 119435, Russia; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Malaya Pirogovskaya Str. 1a, Moscow, 119435, Russia; Moscow Institute of Physics and Technology, Institutskiy Pereulok 9, Dolgoprudny, 141701, Russia; G4_Interact, USERN, University of Pavia, 27100 Pavia, Italy.
| | - Andrey V Aralov
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya Str. 16/10, Moscow, 117997, Russia.
| |
Collapse
|
2
|
Mergemeier K, Galster F, Lehr M. HPLC-UV assay for the evaluation of inhibitors of plasma amine oxidase using crude bovine plasma. J Enzyme Inhib Med Chem 2019; 34:144-149. [PMID: 30427224 PMCID: PMC6237158 DOI: 10.1080/14756366.2018.1524890] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2018] [Revised: 09/04/2018] [Accepted: 09/13/2018] [Indexed: 11/21/2022] Open
Abstract
Recently, we have described a method for evaluation of plasma amine oxidase (PAO) inhibitors, which monitors the formation of 6-(5-phenyl-2H-tetrazol-2-yl)hexanal from the corresponding amine substrate by HPLC with UV-detection using purified bovine PAO. We now investigated, whether crude bovine plasma can be used as enzyme source in this assay instead of the purified enzyme. With the aid of specific inhibitors, it was ensured that there was no detectable activity of other important amine oxidases in the plasma, namely monoamine oxidase (MAO) A and B and diamine oxidase (DAO). For a series of ω-(5-phenyl-2H-tetrazol-2-yl)alkan-1-amine substrates similar conversion rates were measured for both the purified PAO and crude plasma. The inhibition values determined for the PAO inhibitor 2-(4-phenylphenyl)acetohydrazide (16) under different conditions also corresponded. Additionally, inhibition data of the known PAO inhibitor 2-amino-N-(3-phenylbenzyl)acetamide (17) and a newly synthesised meta-substituted derivative of 16 were determined, which together reflect the two-step inhibition mechanism of these covalent inhibitors.
Collapse
Affiliation(s)
- Kira Mergemeier
- Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Münster, Germany
| | - Florian Galster
- Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Münster, Germany
| | - Matthias Lehr
- Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Münster, Germany
| |
Collapse
|
3
|
Mergemeier K, Lehr M. HPLC-UV assays for evaluation of inhibitors of mono and diamine oxidases using novel phenyltetrazolylalkanamine substrates. Anal Biochem 2018; 549:29-38. [PMID: 29550344 DOI: 10.1016/j.ab.2018.03.007] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2017] [Revised: 03/05/2018] [Accepted: 03/12/2018] [Indexed: 10/17/2022]
Abstract
Recently, we have described an HPLC-UV assay for the evaluation of inhibitors of plasma amine oxidase (PAO) using 6-(5-phenyl-2H-tetrazol-2-yl)hexan-1-amine (4) as a new type of substrate. Now we studied, whether this compound or homologues of it can also function as substrate for related amine oxidases, namely diamine oxidase (DAO), monoamine oxidase A (MAO A) and monoamine oxidase B (MAO B). Among these substances, 4 was converted by DAO with the highest rate. The best substrate for MAO A and B was 4-(5-phenyl-2H-tetrazol-2-yl)butan-1-amine (2). To validate the new assays, the inhibition values of known enzyme inhibitors were determined and the data were compared with those obtained with the substrate benzylamine, which is often used in amine oxidase assays. For the DAO inhibitor 2-(4-phenylphenyl)acetohydrazide an about 10fold lower IC50-value against DAO was obtained when benzylamine was applied instead of 4, indicating that 4 binds to the enzyme with higher affinity than benzylamine. The IC50-values of clorgiline and selegiline against MAO A and B, respectively, also decreased (two- and 30fold) replacing 2 by benzylamine. The discrepancies largely disappeared, when the enzymes were pre-incubated with the inhibitors for 15 min. This can be explained with the covalent inhibition mechanism of the inhibitors.
Collapse
Affiliation(s)
- Kira Mergemeier
- Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstrasse 48, 48149 Münster, Germany
| | - Matthias Lehr
- Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstrasse 48, 48149 Münster, Germany.
| |
Collapse
|
4
|
Kim J, Lee IN. Inactivation of bovine plasma amine oxidase by 1,1,1-trihalo-3-aminopropanes. Bioorg Chem 2017; 75:265-273. [PMID: 29054071 DOI: 10.1016/j.bioorg.2017.10.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2017] [Revised: 10/10/2017] [Accepted: 10/13/2017] [Indexed: 11/19/2022]
Abstract
In this paper, we report the inactivation of copper containing bovine plasma amine oxidase (BPAO) by a series of saturated alkylamines containing halogen atoms at γ-position, which are 1,1,1-trihalo-3-aminopropane, 1,1,1-trifluoro-2-hydroxy-3-aminopropane, 1,1,1-trichloro-2-hydroxy-3-aminopropane, and 1,1,1-trichloro-2-(2-phenethyloxy)-3-aminopropane. The trihalo-2-hydroxypropylamine analogs exhibited a time-dependent inactivation behavior of BPAO, with 1,1,1-trifluoro-2-hydroxy-3-aminopropane as the most efficient inactivator. The incorporation of a OH group at β-position increased inactivation efficiency by 10-fold within the trifluoro analogs, and the incorporation of a phenethyloxy group at β-position exhibited a higher efficiency by 3-fold within the trichloro analogs based on I75 values. All four compounds were found to be irreversible inactivators for BPAO.
Collapse
Affiliation(s)
- Jisook Kim
- Department of Chemistry and Physics, University of Tennessee at Chattanooga, Chattanooga, TN 37403, USA.
| | - Irene N Lee
- Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106, USA
| |
Collapse
|
5
|
Chibac AL, Simionescu M, Sacarescu G, Buruiana EC, Sacarescu L. New dansyl labeled polysilane: Synthesis, characterization and sensor application. Eur Polym J 2017. [DOI: 10.1016/j.eurpolymj.2017.08.013] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
6
|
Li LL, Li K, Liu YH, Xu HR, Yu XQ. Red emission fluorescent probes for visualization of monoamine oxidase in living cells. Sci Rep 2016; 6:31217. [PMID: 27499031 PMCID: PMC4976310 DOI: 10.1038/srep31217] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2016] [Accepted: 07/14/2016] [Indexed: 12/20/2022] Open
Abstract
Here we report two novel red emission fluorescent probes for the highly sensitive and selective detection of monoamine oxidase (MAO) with large Stokes shift (227 nm). Both of the probes possess solid state fluorescence and can accomplish the identification of MAO on test papers. The probe MAO-Red-1 exhibited a detection limit down to 1.2 μg mL−1 towards MAO-B. Moreover, the cleavage product was unequivocally conformedby HPLC and LCMS and the result was in accordance with the proposed oxidative deamination mechanism. The excellent photostability of MAO-Red-1 was proved both in vitro and in vivo through fluorescent kinetic experiment and laser exposure experiment of confocal microscopy, respectively. Intracellular experiments also confirmed the low cytotoxity and exceptional cell imaging abilities of MAO-Red-1. It was validated both in HeLa and HepG2 cells that MAO-Red-1 was capable of reporting MAO activity through the variation of fluorescence intensity.
Collapse
Affiliation(s)
- Ling-Ling Li
- Key Laboratory of Green Chemistry and Technology, Ministry of Education,College of Chemistry, Sichuan University, No. 29, Wangjiang Road, Chengdu, 610064, P. R. China
| | - Kun Li
- Key Laboratory of Green Chemistry and Technology, Ministry of Education,College of Chemistry, Sichuan University, No. 29, Wangjiang Road, Chengdu, 610064, P. R. China
| | - Yan-Hong Liu
- Key Laboratory of Green Chemistry and Technology, Ministry of Education,College of Chemistry, Sichuan University, No. 29, Wangjiang Road, Chengdu, 610064, P. R. China
| | - Hao-Ran Xu
- Key Laboratory of Green Chemistry and Technology, Ministry of Education,College of Chemistry, Sichuan University, No. 29, Wangjiang Road, Chengdu, 610064, P. R. China
| | - Xiao-Qi Yu
- Key Laboratory of Green Chemistry and Technology, Ministry of Education,College of Chemistry, Sichuan University, No. 29, Wangjiang Road, Chengdu, 610064, P. R. China
| |
Collapse
|
7
|
HPLC-UV method for evaluation of inhibitors of plasma amine oxidase using derivatization of an aliphatic aldehyde product with TRIS. Anal Bioanal Chem 2016; 408:4799-807. [DOI: 10.1007/s00216-016-9572-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2016] [Revised: 04/13/2016] [Accepted: 04/15/2016] [Indexed: 12/29/2022]
|
8
|
Synthesis, biological evaluation and structure–activity relationships of new phthalazinedione derivatives with vasorelaxant activity. Eur J Med Chem 2014; 82:407-17. [DOI: 10.1016/j.ejmech.2014.05.052] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2013] [Revised: 05/19/2014] [Accepted: 05/22/2014] [Indexed: 11/18/2022]
|
9
|
Morlieras J, Chezal JM, Miot-Noirault E, Roux A, Heinrich-Balard L, Cohen R, Tarrit S, Truillet C, Mignot A, Hachani R, Kryza D, Antoine R, Dugourd P, Perriat P, Janier M, Sancey L, Lux F, Tillement O. Development of gadolinium based nanoparticles having an affinity towards melanin. NANOSCALE 2013; 5:1603-1615. [PMID: 23334308 DOI: 10.1039/c2nr33457g] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Small Rigid Platforms (SRPs) are sub-5 nanometre gadolinium based nanoparticles that have been developed for multimodal imaging and theranostic applications. They are composed of a polysiloxane network surrounded by gadolinium chelates. A covalent coupling with quinoxaline derivatives has been performed. Such derivatives have proven their affinity for melanin frequently expressed in primary melanoma cases. Three different quinoxaline derivatives have been synthesised and coupled to the nanoparticles. The affinity of the grafted nanoparticles for melanin has then been shown in vitro by surface plasmon resonance on a homemade melanin grafted gold chip.
Collapse
Affiliation(s)
- Jessica Morlieras
- Laboratoire de Physico-Chimie des Matériaux Luminescents, UMR 5620 CNRS - Université Claude Bernard Lyon 1, Université de Lyon, 69622 Villeurbanne Cedex, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Armstrong PB, Dembicer EA, DesBois AJ, Fitzgerald JT, Gehrmann JK, Nelson NC, Noble AL, Bunt RC. Investigation of the Electronic Origin of Asymmetric Induction in Palladium-Catalyzed Allylic Substitutions with Phosphinooxazoline (PHOX) Ligands by Hammett and Swain–Lupton Analysis of the 13C NMR Chemical Shifts of the (π-Allyl)palladium Intermediates. Organometallics 2012. [DOI: 10.1021/om3007163] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Paul B. Armstrong
- Department of Chemistry & Biochemistry, Middlebury College, Middlebury, Vermont 05753, United States
| | - Elizabeth A. Dembicer
- Department of Chemistry & Biochemistry, Middlebury College, Middlebury, Vermont 05753, United States
| | - Andrew J. DesBois
- Department of Chemistry & Biochemistry, Middlebury College, Middlebury, Vermont 05753, United States
| | - Jay T. Fitzgerald
- Department of Chemistry & Biochemistry, Middlebury College, Middlebury, Vermont 05753, United States
| | - Janet K. Gehrmann
- Department of Chemistry & Biochemistry, Middlebury College, Middlebury, Vermont 05753, United States
| | - Nathaniel C. Nelson
- Department of Chemistry & Biochemistry, Middlebury College, Middlebury, Vermont 05753, United States
| | - Amelia L. Noble
- Department of Chemistry & Biochemistry, Middlebury College, Middlebury, Vermont 05753, United States
| | - Richard C. Bunt
- Department of Chemistry & Biochemistry, Middlebury College, Middlebury, Vermont 05753, United States
| |
Collapse
|
11
|
Abstract
The early detection of many human diseases is crucial if they are to be treated successfully. Therefore, the development of imaging techniques that can facilitate early detection of disease is of high importance. Changes in the levels of enzyme expression are known to occur in many diseases, making their accurate detection at low concentrations an area of considerable active research. Activatable fluorescent probes show immense promise in this area. If properly designed they should exhibit no signal until they interact with their target enzyme, reducing the level of background fluorescence and potentially endowing them with greater sensitivity. The mechanisms of fluorescence changes in activatable probes vary. This review aims to survey the field of activatable probes, focusing on their mechanisms of action as well as illustrating some of the in vitro and in vivo settings in which they have been employed.
Collapse
Affiliation(s)
- Christopher R Drake
- Department of Radiology and Biomedical Imaging, University of California San Francisco, 185 Berry Street, Suite 350, Box 0946, San Francisco, CA, 94107, USA
| | | | | |
Collapse
|
12
|
Largeron M, Fleury MB, Strolin Benedetti M. A small molecule that mimics the metabolic activity of copper-containing amine oxidases (CuAOs) toward physiological mono- and polyamines. Org Biomol Chem 2010; 8:3796-800. [DOI: 10.1039/c004501b] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
|